Asian markets were mixed Monday as a new, lower-cost AI model from a Chinese startup triggered a sharp sell-off in South Korean tech stocks over valuation concerns, while boosting shares in mainland China and Hong Kong.
The Chinese online healthcare company's stock gained after announcing it will offer Novo Nordisk's Kyinsu treatment, expanding a key partnership and tapping into China's significant market for weight-loss drugs.
A growing number of Indian students are opting for European universities over traditional U.S. destinations, influenced by lower costs, new EU mobility agreements, and stricter American immigration policies.
Global investment firms KKR and AEW Capital Management are seeking buyers for commercial property portfolios in China, reportedly expecting valuations as low as 50% of their original purchase price amid a prolonged market slump.
U.S. stock futures were little changed Sunday evening as investors prepared for a crucial week of corporate earnings while weighing the market impact of rising geopolitical tensions and higher oil prices.
A multi-million dollar fine against US-based e-commerce giant Coupang by South Korean regulators over a data breach is escalating into a diplomatic test, raising concerns in Washington about Seoul's treatment of American businesses.
The Taiwanese electronics giant has reportedly secured its first contract to build AI servers for SpaceX, a deal estimated at $52 billion for over 13,000 racks powered by Nvidia's GB300 chips, according to Taiwan's Economic Daily.
The South Korean contract drug manufacturer aims to acquire Swiss-based PolyPeptide to expand its capabilities in high-growth peptide therapeutics, including obesity and diabetes treatments.
The U.S. Food and Drug Administration has retracted an earlier finding of contamination in a Taylor Farms product, stating that a re-review of the sample concluded the result was a false positive.
